These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28505487)

  • 1. Heroin refusal self-efficacy and preference for medication-assisted treatment after inpatient detoxification.
    Kenney SR; Bailey GL; Anderson BJ; Stein MD
    Addict Behav; 2017 Oct; 73():124-128. PubMed ID: 28505487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification.
    Bailey GL; Herman DS; Stein MD
    J Subst Abuse Treat; 2013 Sep; 45(3):302-5. PubMed ID: 23786852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An expanded self-medication hypothesis based on cognitive-behavioral determinants for heroin abusers in Taiwan: a cross-sectional study.
    Lee KH; Bowen S; Oei TP; Yen CF
    Am J Addict; 2012 Nov; 21 Suppl 1():S43-8. PubMed ID: 23786509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
    McKeganey N; Russell C; Cockayne L
    J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-efficacy Mediates Perceived Benefits and Barriers of Adherence of Heroin-dependent Patients to Methadone for Addiction Treatment: A Health Belief Model Study.
    Yu B; Zhou J; Gong Y; Han J; Dong P; Yang S; Liao R; Guan P; Yang S
    J Addict Med; 2020; 14(4):e110-e117. PubMed ID: 32142052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Satisfaction With Methadone Among Heroin-Dependent Patients With Current Substance Use Disorders During Methadone Maintenance Treatment.
    Perez de Los Cobos J; Trujols J; Siñol N; Duran-Sindreu S; Batlle F
    J Clin Psychopharmacol; 2016 Apr; 36(2):157-62. PubMed ID: 26825608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of opiate users leaving detoxification treatment against medical advice.
    Kenne DR; Boros AP; Fischbein RL
    J Addict Dis; 2010 Jul; 29(3):383-94. PubMed ID: 20635287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-Assisted Treatment for Adolescents in Specialty Treatment for Opioid Use Disorder.
    Feder KA; Krawczyk N; Saloner B
    J Adolesc Health; 2017 Jun; 60(6):747-750. PubMed ID: 28258807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk relapse situations and self-efficacy: comparison between alcoholics and heroin addicts.
    El-Sheikh Sel-G; Bashir TZ
    Addict Behav; 2004 Jun; 29(4):753-8. PubMed ID: 15135557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
    Falcato L; Beck T; Reimer J; Verthein U
    J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine for acute heroin detoxification: diffusion of research into practice.
    Kovas AE; McFarland BH; McCarty DJ; Boverman JF; Thayer JA
    J Subst Abuse Treat; 2007 Mar; 32(2):199-206. PubMed ID: 17306728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.
    Oviedo-Joekes E; Marchand K; Guh D; Marsh DC; Brissette S; Krausz M; Anis A; Schechter MT
    Addict Behav; 2011; 36(1-2):55-60. PubMed ID: 20855171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine.
    Ponizovsky AM; Grinshpoon A; Margolis A; Cohen R; Rosca P
    Addict Behav; 2006 Nov; 31(11):2002-13. PubMed ID: 16524668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of socio-demographic characteristics, substance, and depression among male heroin users attending therapeutic community and methadone maintenance treatment program in Nantou, Taiwan.
    Chen VC; Wu MH; Lin TY; Ho YF; Wang HY; Gossop M
    Subst Abuse Treat Prev Policy; 2015 Oct; 10():41. PubMed ID: 26507876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.